Pfizer Stock Leaps After Q3 Earnings Beat; Sees $36 Billion In COVID Vaccine Sales

Pfizer Stock Leaps After Q3 Earnings Beat; Sees $36 Billion In COVID Vaccine Sales

Source: 
TheStreet.com
snippet: 

Pfizer Inc.  (PFE) - Get Pfizer Inc. Report posted stronger-than-expected third quarter earnings Tuesday, and boosted its full-year profit forecast while lifting its vaccine sales estimate to around $36 billion.